{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:55:49Z","timestamp":1762102549999,"version":"3.30.0"},"reference-count":35,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.3201\/eid2611.202602","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T17:18:32Z","timestamp":1600708712000},"page":"2549-2554","source":"Crossref","is-referenced-by-count":15,"title":["Two Pandemics, One Challenge\u2014Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding"],"prefix":"10.3201","volume":"26","author":[{"given":"Susanne","family":"Homolka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Paulowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f6nke","family":"Andres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Hillemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruwen","family":"Jou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunar","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareli","family":"Claassens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kuhns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian P.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2611.202602-202010161652-R1","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMp2003762","article-title":"Responding to Covid-19\u2014a once-in-a-century pandemic?","volume":"382","author":"Gates","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2611.202602-202010161652-R2","unstructured":"World Health Organization. Coronavirus disease 2019. 2020 [cited 2020 May 6]. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019"},{"key":"key-10.3201\/eid2611.202602-202010161652-R3","unstructured":"WHO Health Emergencies Programme. COVID-19 supply chain system: requesting and receiving supplies. Health emergencies preparedness and response 2020. 2020 [cited 2020 May 6]. https:\/\/www.who.int\/publications\/m\/item\/covid-19-supply-chain-system-requesting-and-receiving-supplies"},{"key":"key-10.3201\/eid2611.202602-202010161652-R4","unstructured":"World Health Organization. COVID-19 strategy update (as of 14 April 2020). Geneva: The Organization; 2020 [cited 2020 May 6]. https:\/\/apps.who.int\/iris\/handle\/10665\/332019"},{"key":"key-10.3201\/eid2611.202602-202010161652-R5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijid.2020.02.049","article-title":"Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future.","volume":"93","author":"Kapata","year":"2020","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2611.202602-202010161652-R6","unstructured":"World Health Organization. WHO African Region: JEE mission reports. 2020 Jan 8 [cited 2020 May 6]. https:\/\/www.who.int\/ihr\/procedures\/mission-reports-africa"},{"key":"key-10.3201\/eid2611.202602-202010161652-R7","unstructured":"Stop TB. Partnership. Considerations for selection of SARS-CoV-2 diagnostics and potential multiplexing: a perspective to ensure continuity of care for people with TB. 2020 [cited 2020 Apr 15]. http:\/\/stoptb.org\/assets\/documents\/covid\/Considerations%20for%20selection%20of%20SARS-CoV-2%20diagnostics.pdf"},{"key":"key-10.3201\/eid2611.202602-202010161652-R8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(19)30263-2","article-title":"The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis.","volume":"7","author":"Dheda","year":"2019","journal-title":"Lancet Respir Med"},{"key":"key-10.3201\/eid2611.202602-202010161652-R9","unstructured":"Cepheid. Cepheid | Xpert\u00ae Xpress SARS-CoV-2 has received FDA Emergency Use Authorization. 2020 [cited 2020 May 6]. https:\/\/www.cepheid.com\/coronavirus"},{"key":"key-10.3201\/eid2611.202602-202010161652-R10","unstructured":"World Health Organization. Considerations for adoption and use of multidisease testing devices in integrated laboratory networks. Geneva: The Organization; 2017 [cited 2020 May 6]. https:\/\/apps.who.int\/iris\/handle\/10665\/255693"},{"key":"key-10.3201\/eid2611.202602-202010161652-R11","unstructured":"World Health Organization. Tuberculosis and COVID-19. COVID-19: considerations for tuberculosis (TB) care. Geneva: The Organization; 2020 [cited 2020 May 6]. https:\/\/www.who.int\/docs\/default-source\/documents\/tuberculosis\/infonote-tb-covid-19.pdf"},{"key":"key-10.3201\/eid2611.202602-202010161652-R12","unstructured":"World Health Organization. Laboratory services in TB control, part I: organization and management. Geneva: The Organization; 1998 [cited 2020 May 6]. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/65942\/WHO_TB_98.258_(part1).pdf"},{"key":"key-10.3201\/eid2611.202602-202010161652-R13","unstructured":"Treatment Action Group. Fair pricing for Cepheid Xpert Tests (COVID-19, HIV, TB, HCV). 2020 Apr 3 [cited 2020 May 12]. https:\/\/www.treatmentactiongroup.org\/webinar\/fair-pricing-for-cepheid-xpert-tests-covid-19-hiv-tb-hcv"},{"key":"key-10.3201\/eid2611.202602-202010161652-R14","unstructured":"Stop TB. Partnership. GDF diagnostics catalog. Geneva: United Nations Office for Project Services; 2020 [cited 2020 May 6]. http:\/\/www.stoptb.org\/assets\/documents\/gdf\/drugsupply\/GDFDiagnosticsCatalog.pdf"},{"key":"key-10.3201\/eid2611.202602-202010161652-R15","unstructured":"International Organization for Standardization. Medical laboratories: requirements for quality and competence. Geneva: The Organization; 2012 [cited 2020 May 6]. https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso:15189:ed-3:v2:en"},{"key":"key-10.3201\/eid2611.202602-202010161652-R16","unstructured":"International Organization for Standardization. ISO\/IEC 17043:2010. Conformity assessment\u2014general requirements for proficiency testing. Geneva: The Organization; 2010 [cited 2020 May 6]. https:\/\/www.iso.org\/standard\/29366.html"},{"key":"key-10.3201\/eid2611.202602-202010161652-R17","first-page":"149","article-title":"ISO 9001: 2015 edition\u2014management, quality and value.","volume":"1","author":"Fonseca","year":"2017","journal-title":"Int J Qual Res"},{"key":"key-10.3201\/eid2611.202602-202010161652-R18","unstructured":"World Health Organization. Laboratory quality management system: handbook. Geneva: The Organization; 2011 [cited 2020 May 6]. https:\/\/www.who.int\/ihr\/publications\/lqms"},{"key":"#cr-split#-key-10.3201\/eid2611.202602-202010161652-R19.1","unstructured":"World Health Organization. Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19): interim guidance. Geneva: The Organization"},{"key":"#cr-split#-key-10.3201\/eid2611.202602-202010161652-R19.2","unstructured":"2020 [cited 2020 May 6]. https:\/\/apps.who.int\/iris\/rest\/bitstreams\/1277819\/retrieve"},{"key":"key-10.3201\/eid2611.202602-202010161652-R20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7554\/eLife.38200","article-title":"Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia.","volume":"7","author":"Merker","year":"2018","journal-title":"eLife"},{"key":"key-10.3201\/eid2611.202602-202010161652-R21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid2611.202602-202010161652-R22","doi-asserted-by":"publisher","first-page":"e1007297","DOI":"10.1371\/journal.ppat.1007297","article-title":"Pathogen-based precision medicine for drug-resistant tuberculosis.","volume":"14","author":"Gr\u00f6schel","year":"2018","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2611.202602-202010161652-R23","doi-asserted-by":"publisher","first-page":"1901154","DOI":"10.1183\/13993003.01154-2019","article-title":"Accuracy of whole-genome sequencing to determine recent tuberculosis transmission: an 11-year population-based study in Hamburg, Germany.","volume":"54","author":"Diel","year":"2019","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2611.202602-202010161652-R24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"CRyPTIC Consortium and the 100,000 Genomes Project. CRyPTIC Consortium and the 100,000 Genomes Project. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing.","volume":"379","author":"Allix-B\u00e9guec","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2611.202602-202010161652-R25","unstructured":"World Health Organization. The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. Geneva: The Organization; 2018 [cited 2020 May 6]. https:\/\/apps.who.int\/iris\/handle\/10665\/274443"},{"key":"key-10.3201\/eid2611.202602-202010161652-R26","unstructured":"Public Health England. England world leaders in the use of whole genome sequencing to diagnose TB. London: Public Health England; 2017 [cited 2020 May 6]. https:\/\/www.gov.uk\/government\/news\/england-world-leaders-in-the-use-of-whole-genome-sequencing-to-diagnose-tb"},{"key":"key-10.3201\/eid2611.202602-202010161652-R27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13073-020-00751-4","article-title":"Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.","volume":"12","author":"Xiao","year":"2020","journal-title":"Genome Med"},{"key":"key-10.3201\/eid2611.202602-202010161652-R28","doi-asserted-by":"publisher","first-page":"9241","DOI":"10.1073\/pnas.2004999117","article-title":"Phylogenetic network analysis of SARS-CoV-2 genomes.","volume":"117","author":"Forster","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2611.202602-202010161652-R29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China.","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"key-10.3201\/eid2611.202602-202010161652-R30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2807\/1560-7917.ES.2020.25.22.2000746","article-title":"Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.","volume":"25","author":"Walker","year":"2020","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2611.202602-202010161652-R31","first-page":"e00187","article-title":"Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options.","volume":"58","author":"Khan","year":"2020","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2611.202602-202010161652-R32","doi-asserted-by":"publisher","first-page":"hvaa187","DOI":"10.1093\/clinchem\/hvaa187","article-title":"SARS-CoV-2 whole genome amplification and sequencing for effective population-based surveillance and control of viral transmission.","author":"Harilal","year":"2020","journal-title":"Clin Chem"},{"key":"key-10.3201\/eid2611.202602-202010161652-R33","unstructured":"Stop TB. Partnership. We did a rapid assessment: the TB response is heavily impacted by the COVID-19 pandemic. 2020 [cited 2020 May 10]. http:\/\/www.stoptb.org\/news\/stories\/2020\/ns20_014.html"},{"key":"key-10.3201\/eid2611.202602-202010161652-R34","unstructured":"Stop TB. Partnership. The potential impact of the covid-19 response on tuberculosis in high-burden countries: a modelling analysis. Geneva: United Nations Office for Project Services; 2020 [cited 2020 May 6]. http:\/\/www.stoptb.org\/assets\/documents\/news\/Modeling%20Report_1%20May%202020_FINAL.pdf"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/26\/11\/20-2602_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:31:31Z","timestamp":1732987891000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/26\/11\/20-2602_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2611.202602","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}